HEMANGIOSARCOMA
Article written by Dr. MaryDee Sist, DVM
SALUKI HEART HEMANGIOSARCOMA — partial outline of the presentation given at the annual meeting of the American Association of Veterinary Laboratory Diagnosticians, Nov. 2000 by Tom Bell DVM PhD, Pathologist, Animal Health Diagnostic Laboratory, Michigan State University and MaryDee Sist DVM, Saluki Health Research
HEMANGIOSARCOMA (HSA)
By actively soliciting owner submissions of Saluki hearts, it is apparent that we have uncovered an alarming incidence of cancer in our breed. Saluki Health Research continues to finance this study and is exploring various avenues of further investigation.
SALUKI HEART HEMANGIOSARCOMA — partial outline of the presentation given at the annual meeting of the American Association of Veterinary Laboratory Diagnosticians, Nov. 2000 by Tom Bell DVM PhD, Pathologist, Animal Health Diagnostic Laboratory, Michigan State University and MaryDee Sist DVM, Saluki Health Research
HEMANGIOSARCOMA (HSA)
- Is a highly malignant tumor of cells lining the inside of blood vessels
- Appear as blood filled cysts
- Readily spread via the blood stream
- Sites ~ skin 33%, spleen 29%, heart (CHSA) 7%, other 31%
- Occurs in the right atrium of the heart
- Has a poor long-term prognosis
- Is not amenable to surgical removal
- Metastasizes to the lungs, liver and spleen
- Reported to make up 46% of cardiac tumors*
- HSA ~ 0.86% of all biopsy/necropsy (659/77,883) samples 1990-99
- CHSA ~ 0.073% (56/77,883)
- CHSA ~ 0.087% (633/729,265) National VMDB 1982-95*
- Initially cardiomyopathy was the concern
- Hearts were requested from sudden death dogs
- 55 Saluki hearts were examined as of June, 2000
- 31% of the Saluki hearts received had CHSA (17/55)
- Saluki (17/55) = 30.9%
- Golden Retriever (119/5196) = 0.023%
- German Shepherd (37/2796) = 0.013%
- Labrador Retriever (47/5159) =0.009%
- Boxer (16/2033) = 0.008%
- Both VMDB* and MSU data suggest SALUKI breed susceptibility to tumor induction
- VMDB* data suggests breed resistance (Pomeranian, Pug, Jack Russell and Cocker)
- 47% had one or more form of cancer
- 58% had myxomatous mitral valve degenerative changes
- 47% had narrowing of the small arteries in the heart
- 5% had congenital tricuspid insufficiency
- 5% had mineralization of the aorta
- 2% had congenital mitral insufficiency
- 2 dogs had cardiomyopathy
By actively soliciting owner submissions of Saluki hearts, it is apparent that we have uncovered an alarming incidence of cancer in our breed. Saluki Health Research continues to finance this study and is exploring various avenues of further investigation.